Exploring Accessible Beauty for Individuals With Upper Extremity Deficits (NCT05945784) | Clinical Trial Compass
CompletedNot Applicable
Exploring Accessible Beauty for Individuals With Upper Extremity Deficits
United States57 participantsStarted 2023-07-21
Plain-language summary
The purpose of this study is to investigate the accessibility of beauty products for individuals with upper extremity disabilities. By examining various factors such as packaging design, product applicators, and ease of use, this research aims to identify barriers faced by individuals with upper extremity disabilities or visual deficits when using beauty products. The study seeks to provide insights and recommendations for improving the accessibility of beauty products, ultimately promoting inclusivity and enhancing the overall beauty experience for individuals with disabilities.
Who can participate
Age range
18 Years – 55 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Individuals aged 18 years to 55 years.
* Minimal to moderate upper extremity deficits, including but not limited to limited mobility or dexterity impairments.
* Regular users beauty products.
* Able to understand and communicate in the language of the study.
Exclusion Criteria:
* Individuals below 18 years of age or over the age of 55.
* Individuals without upper extremity deficits or with severe upper extremity deficits that may affect the participant's ability to engage in study activities.
* Participants who are not regular users of beauty products.
* Inability to understand and communicate in the language of the study.
* Any medical or psychological condition that may affect the participant's ability to provide informed consent or engage in the study activities safely.
* Individuals who experience facial skin or eye irritation reported by subject or observed by evaluator at baseline visit
* History of allergic reactions, and/or known allergies to cosmetic ingredients, toiletries, sunscreens, etc.
* Immunocompromised subjects
* Individuals who may experience changes in hormones, such as just those using oral contraception for less than three months before the screening visit or who have changed hormonal contraceptive methods within the three months before the Baseline visit or planning to modify hormonal contraception treatment within the duration of the study.
* Known to be pregnant, lactating or planning to become pregnant within six months. Subje…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Likert Scale
Timeframe: Complete on Day 7
2
Likert Scale
Timeframe: Complete on Day 14
3
Pre-test Questionnaire
Timeframe: At baseline
4
Accessibility Evaluation
Timeframe: Day 7, after use of beauty products
5
Accessibility Evaluation
Timeframe: Day 14, after use of beauty products at end of study
6
Post-test Questionnaire
Timeframe: Day 14, after use of beauty products at end of study
Trial details
NCT IDNCT05945784
SponsorCasa Colina Hospital and Centers for Healthcare